Wesfarmers delivered a solid first-half result for 2026, demonstrating the resilience of its diversified business while highlighting the growing strategic importance of Wesfarmers Health. …
Wesfarmers Health emerges as growth engine after delivering strong first half
February 19, 2026 Australian BiotechBioPharma
Latest Video
Georgia Forrest
New Stories
-
Wesfarmers Health emerges as growth engine after delivering strong first half
February 19, 2026 - - Australian Biotech -
Telix files for European approval of brain cancer imaging candidate TLX101-Px
February 18, 2026 - - Australian Biotech -
IDT signals turnaround as revenue rises and losses narrow under strategic reset
February 18, 2026 - - Latest News -
Nyrada advances lead candidate into mid-stage trial as momentum builds across programs
February 18, 2026 - - Australian Biotech -
AusBiotech–Proto Axiom alliance aims to fast-track Australia’s next wave of biotech innovators
February 18, 2026 - - Latest News -
Novo Nordisk backs community-led initiative that aims to transform life for Logan’s children
February 18, 2026 - - Latest News -
CSL and Lilly strike strategic deal to advance promising anti-inflammatory therapy
February 18, 2026 - - Latest News